Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index; 3 of the 33 sources its claims cite were checked for support.

Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis

Open access

Published version of a preprint

Abstract

Digital measures of health status captured during daily life could greatly augment current in-clinic assessments for rheumatoid arthritis (RA), to enable better assessment of disease progression and impact. This work presents results from weaRAble-PRO, a 14-day observational study, which aimed to investigate how digital health technologies (DHT), such as smartphones and wearables, could augment patient reported outcomes (PRO) to determine RA status and severity in a study of 30 moderate-to-severe RA patients, compared to 30 matched healthy controls (HC). Sensor-based measures of health status, mobility, dexterity, fatigue, and other RA specific symptoms were extracted from daily iPhone guided tests (GT), as well as actigraphy and heart rate sensor data, which was passively recorded from patients’ Apple smartwatch continuously over the study duration. We subsequently developed a machine learning (ML) framework to distinguish RA status and to estimate RA severity. It was found that daily wearable sensor-outcomes robustly distinguished RA from HC participants (F1, 0.807). Furthermore, by day 7 of the study (half-way), a sufficient volume of data had been collected to reliably capture the characteristics of RA participants. In addition, we observed that the detection of RA severity levels could be improved by augmenting standard patient reported outcomes with sensor-based features (F1, 0.833) in comparison to using PRO assessments alone (F1, 0.759), and that the combination of modalities could reliability measure continuous RA severity, as determined by the clinician-assessed RAPID-3 score at baseline ( r 2 , 0.692; RMSE, 1.33). The ability to measure the impact of the disease during daily life—through objective and remote digital outcomes—paves the way forward to enable the development of more patient-centric and personalised measurements for use in RA clinical trials.

Overview

CoChat Summary

TL;DR

In a 14-day observational study, smartphone guided tests and smartwatch passive monitoring distinguished rheumatoid arthritis (RA) participants from healthy controls and augmented patient-reported outcomes to estimate RA severity. Combining active and passive sensor features improved RA identification and severity estimation, with sufficient data by day 7.

Key findings

  • Combined active + passive wearable sensor features best distinguished RA from healthy controls (F1, 0.807), compared with passive-only (F1, 0.786) or active-only (F1, 0.778) features.
  • RA severity level estimation improved when PROs were augmented with both active and passive sensor outcomes (F1, 0.833) versus PRO assessments alone (F1, 0.759).
  • PRO + sensor-based features estimated continuous clinician-assessed RAPID-3 scores with r² = 0.692 and RMSE = 1.33, improving on PRO measures alone (r² = 0.63; RMSE = 1.45).
  • By day 7 of the 14-day study, enough data had been collected to reliably capture RA characteristics; model performance and feature reliability stabilised after more than 7 days.

Methods

  • Design: 14-day observational study (weaRAble-PRO) with 30 moderate-to-severe RA patients and 30 matched healthy controls; after two RA withdrawals, 28 RA participants, 28 matched HCs, and 2 unmatched HCs remained (total 58).
  • Data: daily iPhone guided tests (wrist range of motion, 30-second walking, nine-hole peg test, sit-to-stand, lie-to-stand), continuous Apple Watch actigraphy, and PROs recorded on days 1, 7, and 14.
  • Analysis: machine learning framework using a DCNN pretrained with self-supervised learning on UK Biobank data and fine-tuned on Capture-24, plus an HMM; regularised logistic regression, random forest, and XGBoost compared with stratified subject-wise 5-fold cross-validation; metrics included F1, AUROC, Cohen’s kappa, r², MAE, RMSE, and ICC.

Limitations

  • The paper states a relatively small sample size (HC, n = 30; RA, n = 30), causing variability and uncertainty in cross-validated models; extrapolation to general RA populations requires larger cohorts and further external validation.
  • The paper states that only moderate-to-severe RA patients were recruited, so lower disease activity or remission was not characterised.
  • The paper notes that RAPID-3 was assessed at baseline with recall of the prior week, while PRO and sensor features were averaged over the subsequent 14 days, and that PRO predictors are subjective; evident from the text, the study is a single cohort without external validation beyond the internal JMAP inspection.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41746-024-01013-y

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Illustration detailing the objectives of this study. The weaRAble-PRO 14-day trial aimed to investigate how digital health technologies (DHT)—a wrist-worn Apple smartwatch and an iPhone device, with bespoke mobile apps.—could augment patient reported outcomes (PRO) to characterise the impact of rheumatoid arthritis (RA) during the daily life of 30 moderate-to-severe RA patients, compared to 30 matched healthy controls (HC). We explore the ability of machine learning (ML) models to (1) estimate categorical RA outcomes, such as identifying RA participants from healthy controls and (2) estimate continuous RA outcomes, such as RA severity, using a combination of PRO and sensor-outcomes.
Fig. 1 Illustration detailing the objectives of this study. The weaRAble-PRO 14-day trial aimed to investigate how digital health technologies (DHT)—a wrist-worn Apple smartwatch and an iPhone device, with bespoke mobile apps.—could augment patient reported outcomes (PRO) to characterise the impact of rheumatoid arthritis (RA) during the daily life of 30 moderate-to-severe RA patients, compared to 30 matched healthy controls (HC). We explore the ability of machine learning (ML) models to (1) estimate categorical RA outcomes, such as identifying RA participants from healthy controls and (2) estimate continuous RA outcomes, such as RA severity, using a combination of PRO and sensor-outcomes.CC BY · PubMed Central
Fig. 2 Ability of individual sensor-outcomes to distinguish between RA status and RA severity levels. Comparison of the average feature distributions per participants, between healthy controls (HC), RA (moderate) and RA (severe) groups for: a–c selection of passively collected smartwatch features; d–f selection of guided test collected smartphone features; and g–i selection of patient self-reported outcomes recorded on the smartphone application. For all examples shown, medians were significantly different between HC and RA groups: One-way ANOVA determined from the Kruskal-Wallis H-test, p < 0.001. deg degrees, HAQ-DI Health Assessment Questionnaire-Disability Index, min minutes, mg mili-gravity acceleration units, MVPA moderate-to-vigorous physical activity, RASIQ GSK RA symptom and impact questionnaire, sed sedentary, sec seconds.
Fig. 2 Ability of individual sensor-outcomes to distinguish between RA status and RA severity levels. Comparison of the average feature distributions per participants, between healthy controls (HC), RA (moderate) and RA (severe) groups for: a–c selection of passively collected smartwatch features; d–f selection of guided test collected smartphone features; and g–i selection of patient self-reported outcomes recorded on the smartphone application. For all examples shown, medians were significantly different between HC and RA groups: One-way ANOVA determined from the Kruskal-Wallis H-test, p < 0.001. deg degrees, HAQ-DI Health Assessment Questionnaire-Disability Index, min minutes, mg mili-gravity acceleration units, MVPA moderate-to-vigorous physical activity, RASIQ GSK RA symptom and impact questionnaire, sed sedentary, sec seconds.CC BY · PubMed Central
Fig. 3 Ability of combined sensor-outcomes to distinguish between RA status and RA severity levels. Comparison of a RA identification (RA vs. HC) performance and b RA severity level estimation (RA (mod) vs RA (sev)), using patient reported outcomes (PRO) and combined PRO (list icon), active (smartphone icon), and passive (smartwatch icon) sensor-based outcomes in the weaRAble-PRO study. auroc area under the receiver operator curve, κ Cohen’s Kappa statistic, F1 macro-F1 score.
Fig. 3 Ability of combined sensor-outcomes to distinguish between RA status and RA severity levels. Comparison of a RA identification (RA vs. HC) performance and b RA severity level estimation (RA (mod) vs RA (sev)), using patient reported outcomes (PRO) and combined PRO (list icon), active (smartphone icon), and passive (smartwatch icon) sensor-based outcomes in the weaRAble-PRO study. auroc area under the receiver operator curve, κ Cohen’s Kappa statistic, F1 macro-F1 score.CC BY · PubMed Central
Fig. 4 The number of days of sensor-data required to remotely characterise RA impact. Comparison of a the minimal amount of days of data needed distinguish RA status, as measured by the F1 score across 5-fold cross validation (CV), between active (smartphone icon), passive (smartwatch icon), and combined (smartphone & smartwatch icons) feature sources; b the feature (test-retest) reliability, as measured by the intraclass correlation coefficient (ICC), between RA participants and HC across the study duration (14 days); F1 scores and ICCs suggest that model performance and feature reliability stabilises once more than 7 days of data are used per participant.
Fig. 4 The number of days of sensor-data required to remotely characterise RA impact. Comparison of a the minimal amount of days of data needed distinguish RA status, as measured by the F1 score across 5-fold cross validation (CV), between active (smartphone icon), passive (smartwatch icon), and combined (smartphone & smartwatch icons) feature sources; b the feature (test-retest) reliability, as measured by the intraclass correlation coefficient (ICC), between RA participants and HC across the study duration (14 days); F1 scores and ICCs suggest that model performance and feature reliability stabilises once more than 7 days of data are used per participant.CC BY · PubMed Central
Fig. 5 The number of sensor-outcomes required to remotely distinguish RA status. Comparison of features selected between regularised logistic regression (LR) models for: a elastic-net (F1, 0.79) and b SG-lasso (F1, 0.81). The SG-lasso promotes group-wise sparsity (i.e., regularising the number of feature domains) and within-group sparsity (i.e., regularising the number of features per domain), achieving a similar performance to LR elastic-net, while selecting a fewer number of domains and features. Feature importance, denoted as the mean LR coefficient value (w) over cross-validation, are illustrated by colour intensity. Feature domains: AF activity fragmentation, DEM demographics, LTS lie-to-stand assessment, MORN morning stiffness, NTR night-time restlessness, PEG 9-hole peg test, STS sit-to-stand assessment, TVDA total volume of daytime activity, WLK walking assessment, WRT wrist assessment.
Fig. 5 The number of sensor-outcomes required to remotely distinguish RA status. Comparison of features selected between regularised logistic regression (LR) models for: a elastic-net (F1, 0.79) and b SG-lasso (F1, 0.81). The SG-lasso promotes group-wise sparsity (i.e., regularising the number of feature domains) and within-group sparsity (i.e., regularising the number of features per domain), achieving a similar performance to LR elastic-net, while selecting a fewer number of domains and features. Feature importance, denoted as the mean LR coefficient value (w) over cross-validation, are illustrated by colour intensity. Feature domains: AF activity fragmentation, DEM demographics, LTS lie-to-stand assessment, MORN morning stiffness, NTR night-time restlessness, PEG 9-hole peg test, STS sit-to-stand assessment, TVDA total volume of daytime activity, WLK walking assessment, WRT wrist assessment.CC BY · PubMed Central
Fig. 6 The ability of remote PRO + sensor-outcomes to estimate in-clinic determined RA severity scores. Scatter plot of baseline RAPID-3 scores y versus predicted y^ scores per subject, using elastic net with PRO + sensor-outcomes, over cross-validation (CV). Participant model-estimated RAPID-3 scores can be further interpreted through detailed inspection of the daily smartphone-based patient-reported joint pain map (JMAP) total scores—which was not included as a predictor in the model. Higher JMAP scores indicate higher levels of pain experienced. Additional interpretability, through the JMAP, demonstrated that PRO + sensor-based outcome estimation of the RAPID-3 could reliably reflect patient’s perceived daily RA symptoms. Note: Baseline JMAP total scores, recorded on the same day as the baseline RAPID-3, are denoted in grey; the JMAP y-axis scale is the same among all subplots. HC subjects were assigned a RAPID-3 score of zero at baseline. A black line represents perfect predictions (r2, 0.692; MAE, 0.938; RMSE, 1.333).
Fig. 6 The ability of remote PRO + sensor-outcomes to estimate in-clinic determined RA severity scores. Scatter plot of baseline RAPID-3 scores y versus predicted y^ scores per subject, using elastic net with PRO + sensor-outcomes, over cross-validation (CV). Participant model-estimated RAPID-3 scores can be further interpreted through detailed inspection of the daily smartphone-based patient-reported joint pain map (JMAP) total scores—which was not included as a predictor in the model. Higher JMAP scores indicate higher levels of pain experienced. Additional interpretability, through the JMAP, demonstrated that PRO + sensor-based outcome estimation of the RAPID-3 could reliably reflect patient’s perceived daily RA symptoms. Note: Baseline JMAP total scores, recorded on the same day as the baseline RAPID-3, are denoted in grey; the JMAP y-axis scale is the same among all subplots. HC subjects were assigned a RAPID-3 score of zero at baseline. A black line represents perfect predictions (r2, 0.692; MAE, 0.938; RMSE, 1.333).CC BY · PubMed Central
Fig. 7 Self-supervised learning pipeline. Continuous (passive) actigraphy was recorded from patients' Apple smartwatch over the study duration. Deep convolutional neural networks (DCNN) were pre-trained on 700,000 person days in the publicly available UK Biobank using self-supervised learning—and fine-tuned with the Capture-24 dataset—to estimate participant’s daily activity patterns in the weaRAble-PRO study. Physical activity (PA) metrics of daily-life, for example, the time spent walking, the frequency of exercise, or the length and quality of sleep were investigated as markers to characterise symptoms of disease in people with RA compared to HC.
Fig. 7 Self-supervised learning pipeline. Continuous (passive) actigraphy was recorded from patients' Apple smartwatch over the study duration. Deep convolutional neural networks (DCNN) were pre-trained on 700,000 person days in the publicly available UK Biobank using self-supervised learning—and fine-tuned with the Capture-24 dataset—to estimate participant’s daily activity patterns in the weaRAble-PRO study. Physical activity (PA) metrics of daily-life, for example, the time spent walking, the frequency of exercise, or the length and quality of sleep were investigated as markers to characterise symptoms of disease in people with RA compared to HC.CC BY · PubMed Central

Verification

Claims the paper makes

2 Valid · 1 Not valid · 20 Not checked · 58 Own results and interpretations

43 more claims

Create a free account to see all 81 claims and to verify the 30 references still open.

See all claims — free account
  • Probably not a substantial claim. 22
  • It may state two separate claims as one. 18
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 82 references

Research works printed but not linked: 3

  1. Hollander, M., Wolfe, D. A. & Chicken, E. Nonparametric statistical methods, Vol. 751 (John Wiley & Sons, 2013).
  2. Gibbons, J. D. & Chakraborti, S. Nonparametric Statistical Inference: Revised and Expanded (CRC press, 2014).
  3. Portney, L. G. & Watkins, M. P. Foundations of clinical research: applications to practice, vol. 892 (Pearson/Prentice Hall Upper Saddle River, NJ, 2009).

Cited by

See all 70

Metadata

Authors
Creagh, A. P., Hamy, V., Yuan, H., Mertes, G., Tomlinson, R., Chen, W.-H., Williams, R., Llop, C., Yee, C., Duh, M. S., Doherty, A., Garcia-Gancedo, L., & Clifton, D. A.
Affiliations
  • University of Oxford (GB)
  • Analysis Group (United States) (US)
Corresponding author
Creagh, Andrew P.
Venue
npj Digital Medicine
Published
2024-02-12
Volume
7
Issue
1
Pages
33-33
ISSN
2398-6352 (ISSN-L)
OpenAlex
W4391751277
Cited by
64
References
82
Citations by year
2026: 23 · 2025: 23 · 2024: 15
FWCI
19.75
Type
journal article
Language
en
Open access
Licence
Locations
  • npj Digital Medicine (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • GlaxoSmithKline
  • Wellcome Trust (223100/Z/21/Z)
  • National Institute for Health and Care Research
Topics
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Context-Aware Activity Recognition Systems
Keywords
rheumatoid arthritis, patient-reported outcomes, digital health technologies, wearable sensors, smartphone health monitoring, actigraphy, heart rate monitoring, remote patient monitoring, fatigue, clinical trial outcome measures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis. https://app.cochat.ai/papers/10.1038/s41746-024-01013-y
The paper
Creagh, A. P., Hamy, V., Yuan, H., Mertes, G., Tomlinson, R., Chen, W.-H., Williams, R., Llop, C., Yee, C., Duh, M. S., Doherty, A., Garcia-Gancedo, L., & Clifton, D. A. (2024). Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis. npj Digital Medicine. https://doi.org/10.1038/s41746-024-01013-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.